Right ventricular myocardial infarction: Difference between revisions
No edit summary |
|||
| Line 31: | Line 31: | ||
==Treatment== | ==Treatment== | ||
[[Right ventricular myocardial infarction initial care|Initial Care]] | [[Right ventricular myocardial infarction initial care|Initial Care]] | ||
'''Pharmacologic Reperfusion''' | [[ST elevation myocardial infarction reperfusion therapy|Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI)]] | [[ST elevation myocardial infarction fibrinolytic therapy|Fibrinolysis]] | |||
'''Mechanical Reperfusion''' | [[Door-to-Balloon|The importance of reducing Door-to-Balloon times]] | [[ST elevation myocardial infarction primary percutaneous coronary intervention|Primary PCI]] | [[ST elevation myocardial infarction percutaneous coronary intervention following fibrinolytic administration|Adjunctive and Rescue PCI]] | [[ST elevation myocardial infarction rescue percutaneous coronary intervention|Rescue PCI]] | | |||
[[ST elevation myocardial infarction facilitated percutaneous coronary intervention|Facilitated PCI]] | | |||
[[ST Elevation Myocardial Infarction Adjunctive Percutaneous Coronary Intervention|Adjunctive PCI]] | | |||
[[ST elevation myocardial infarction coronary artery bypass grafting|CABG]] | [[ST elevation myocardial infarction management of patients who were not reperfused|Management of Patients Who Were Not Reperfused]] | [[ST elevation myocardial infarction assessing success of reperfusion|Assessing Success of Reperfusion]] | |||
'''Antithrombin Therapy''' • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy|Antithrombin therapy]] • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Unfractionated Heparin|Unfractionated heparin]] • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Enoxaparin|Low Molecular Weight Heparinoid Therapy]] • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Bivalirudin|Direct Thrombin Inhibitor Therapy]] • [[ST elevation myocardial infarction anticoagulant and antithrombotic therapy#Fondaparinux|Factor Xa Inhibition]] • [[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|DVT prophylaxis]] • [[ST elevation myocardial infarction deep vein thrombosis prophylaxis and anticoagulation|Long term anticoagulation]] | |||
'''Antiplatelet Agents''' | [[ST elevation myocardial infarction aspirin therapy|Aspirin]] | [[ST elevation myocardial infarction thienopyridine therapy|Thienopyridine Therapy]] | [[ST elevation myocardial infarction glycoprotein IIbIIIa inhibition|Glycoprotein IIbIIIa Inhibition]] | |||
'''Other Initial Therapy''' | [[ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system at discharge|Inhibition of the Renin-Angiotensin-Aldosterone System]] | [[ST elevation myocardial infarction magnesium therapy|Magnesium Therapy]] | [[ST elevation myocardial infarction glucose control|Glucose Control]] | [[ST elevation myocardial infarction calcium channel blocker therapy|Calcium Channel Blocker Therapy]] | |||
==External links== | ==External links== | ||
* [http://hp2010.nhlbihin.net/atpiii/calculator.asp?usertype=pub Risk Assessment Tool for Estimating Your 10-year Risk of Having a Heart Attack] - based on information of the [[Framingham Heart Study]], from the United States [[National Heart, Lung and Blood Institute]] | * [http://hp2010.nhlbihin.net/atpiii/calculator.asp?usertype=pub Risk Assessment Tool for Estimating Your 10-year Risk of Having a Heart Attack] - based on information of the [[Framingham Heart Study]], from the United States [[National Heart, Lung and Blood Institute]] | ||
Revision as of 01:34, 12 September 2012
| Myocardial infarction | |
| ICD-10 | I21-I22 |
|---|---|
| ICD-9 | 410 |
| DiseasesDB | 8664 |
|
Right ventricular myocardial infarction Microchapters |
|
Differentiating Right ventricular myocardial infarction from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Pharmacological Reperfusion |
|
Mechanical Reperfusion |
|
Antithrombin Therapy |
|
Antiplatelet Agents |
|
Other Initial Therapy |
|
Right ventricular myocardial infarction On the Web |
|
Directions to Hospitals Treating Right ventricular myocardial infarction |
|
Risk calculators and risk factors for Right ventricular myocardial infarction |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Patient Info
Overview
Pathophysiology
Causes of Right ventricular myocardial infarction
Differentiating Right ventricular myocardial infarction from other Diseases
Epidemiology & Demographics
Risk Factors
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Criteria
History & Symptoms | Physical Examination | Electrocardiogram | Chest X Ray | Echocardiography or Ultrasound | Coronary Angiography
Treatment
Initial Care Pharmacologic Reperfusion | Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) | Fibrinolysis
Mechanical Reperfusion | The importance of reducing Door-to-Balloon times | Primary PCI | Adjunctive and Rescue PCI | Rescue PCI | Facilitated PCI | Adjunctive PCI | CABG | Management of Patients Who Were Not Reperfused | Assessing Success of Reperfusion
Antithrombin Therapy • Antithrombin therapy • Unfractionated heparin • Low Molecular Weight Heparinoid Therapy • Direct Thrombin Inhibitor Therapy • Factor Xa Inhibition • DVT prophylaxis • Long term anticoagulation
Antiplatelet Agents | Aspirin | Thienopyridine Therapy | Glycoprotein IIbIIIa Inhibition
Other Initial Therapy | Inhibition of the Renin-Angiotensin-Aldosterone System | Magnesium Therapy | Glucose Control | Calcium Channel Blocker Therapy
External links
- Risk Assessment Tool for Estimating Your 10-year Risk of Having a Heart Attack - based on information of the Framingham Heart Study, from the United States National Heart, Lung and Blood Institute
- American Heart Association's Heart Attack web site - Information and resources for preventing, recognizing and treating heart attack.